Correlation Between Cresud SACIF and Finch Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cresud SACIF and Finch Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cresud SACIF and Finch Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cresud SACIF y and Finch Therapeutics Group, you can compare the effects of market volatilities on Cresud SACIF and Finch Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cresud SACIF with a short position of Finch Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cresud SACIF and Finch Therapeutics.
Diversification Opportunities for Cresud SACIF and Finch Therapeutics
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Cresud and Finch is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Cresud SACIF y and Finch Therapeutics Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Finch Therapeutics and Cresud SACIF is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cresud SACIF y are associated (or correlated) with Finch Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Finch Therapeutics has no effect on the direction of Cresud SACIF i.e., Cresud SACIF and Finch Therapeutics go up and down completely randomly.
Pair Corralation between Cresud SACIF and Finch Therapeutics
If you would invest 844.00 in Cresud SACIF y on October 6, 2024 and sell it today you would earn a total of 500.00 from holding Cresud SACIF y or generate 59.24% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 1.61% |
Values | Daily Returns |
Cresud SACIF y vs. Finch Therapeutics Group
Performance |
Timeline |
Cresud SACIF y |
Finch Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Cresud SACIF and Finch Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cresud SACIF and Finch Therapeutics
The main advantage of trading using opposite Cresud SACIF and Finch Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cresud SACIF position performs unexpectedly, Finch Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Finch Therapeutics will offset losses from the drop in Finch Therapeutics' long position.Cresud SACIF vs. Griffon | Cresud SACIF vs. Matthews International | Cresud SACIF vs. Valmont Industries | Cresud SACIF vs. Steel Partners Holdings |
Finch Therapeutics vs. Werewolf Therapeutics | Finch Therapeutics vs. Edgewise Therapeutics | Finch Therapeutics vs. Celcuity LLC | Finch Therapeutics vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |